---
title: "Maestros Mediline Systems Ltd (501209) — Share Price, Financials & Analysis"
symbol: "501209"
company: "Maestros Mediline Systems Ltd"
canonical: "https://tapetide.com/stocks/501209"
isin: "INE408E01027"
bse_code: "501209"
generated_at: "2026-10-13T10:59:14.891Z"
---

# Maestros Mediline Systems Ltd (501209)

Canonical page: https://tapetide.com/stocks/501209

## Company

- **BSE Code:** 501209
- **ISIN:** INE408E01027
- **Stock Type:** EQUITY
- **Listed Since:** 2006-03-01
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** maestros.net

## About

Maestros is India's leading medical diagnostic equipment and services organizations, which focuses on empowering medical professionals and institutions, that treat cardiac, gynecology and critical care patients across the country.

## Latest Price

## Key Insights

### Weaknesses

- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -57.8% over past five years.
- Company has high debtors of 1,251 days.

## Growth Rates

| Metric | 1Y | 3Y | 5Y |
| --- | --- | --- | --- |
| net income growth | 87% | 22% | — |
| revenue growth | -87% | -70% | -58% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Jun 2013 | Sep 2013 | Dec 2013 | Jun 2014 | Sep 2014 |
| --- | --- | --- | --- | --- | --- |
| Sales | 3.44 | 1.97 | 0.26 | 1.09 | 1.07 |
| Expenses | 4.41 | 0.05 | 0.36 | 0.58 | 1.76 |
| Operating Profit | -0.97 | 1.92 | -0.1 | 0.51 | -0.69 |
| OPM % | -28.2 | 97.46 | -38.46 | 46.79 | -64.49 |
| Other Income | 0 | 0 | 0.02 | 0 | 0 |
| Interest | 0.18 | 0.01 | 0 | 0 | 0.01 |
| Depreciation | 0.48 | 0.51 | 0.48 | 0.18 | 0.19 |
| Profit before tax | -1.63 | 1.4 | -0.56 | 0.33 | -0.89 |
| Tax % | 0 | 0 | 0 | 0 | 0 |
| Net Profit | -1.63 | 1.4 | -0.57 | 0.32 | -0.89 |
| EPS in Rs | -3.7 | 3.18 | -1.3 | 0.73 | -2.02 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 33.81 | 29.23 | 30.05 | 41.78 | 42.4 | 21.75 | 7.02 | 4.23 | 0.56 |
| Expenses | 30.28 | 25.66 | 26.06 | 33.48 | 34.79 | 31.93 | 20.46 | 25.74 | 2.99 |
| Operating Profit | 3.53 | 3.57 | 3.99 | 8.3 | 7.61 | -10.18 | -13.44 | -21.51 | -2.43 |
| OPM % | 10.44 | 12.21 | 13.28 | 19.87 | 17.95 | -46.8 | -191.45 | -508.51 | -433.93 |
| Other Income | 0.27 | 0.59 | 0.94 | 0.8 | 0.23 | 0.76 | -0.88 | 0.04 | 0.14 |
| Interest | 1.59 | 1.84 | 2.39 | 2.95 | 4.04 | 5.38 | 0.37 | 0.03 | 0.02 |
| Depreciation | 1.27 | 1.26 | 1.76 | 2.37 | 1.86 | 2.06 | 1 | 0.79 | 0.7 |
| Profit before tax | 0.94 | 1.06 | 0.78 | 3.78 | 1.94 | -16.86 | -15.69 | -22.29 | -3.01 |
| Tax % | 44.68 | 75.47 | 23.08 | 2.91 | -7.73 | -7.41 | 0 | 0 | 0 |
| Net Profit | 0.52 | 0.26 | 0.6 | 3.67 | 2.08 | -15.61 | -15.69 | -22.29 | -3 |
| EPS in Rs | — | 0.59 | 1.36 | 8.34 | 4.73 | -35.48 | -35.66 | -50.66 | -6.82 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 4.55 | 4.42 | 4.37 | 4.37 | 4.37 | 4.37 | 4.37 | 4.37 | 4.37 |
| Reserves | 30.89 | 30.77 | 31.23 | 34.97 | 13.15 | -2.56 | -18.39 | -41.46 | -44.46 |
| Borrowings | 4.39 | 7.79 | 7.5 | 11.72 | 38.96 | 49.68 | 51.06 | 54.1 | 54.37 |
| Other Liabilities | 18.6 | 23.58 | 26 | 24.39 | 21.25 | 22.43 | 20.16 | 5.91 | 7.79 |
| Total Liabilities | 58.43 | 66.56 | 69.1 | 75.45 | 77.73 | 73.92 | 57.2 | 22.92 | 22.07 |
| Fixed Assets | 23.17 | 28.04 | 28.19 | 31.14 | 15.62 | 15.28 | 13.45 | 11.89 | 11.19 |
| CWIP | 0.18 | 0.36 | 0 | 0 | 7.4 | 0 | 0 | 0 | 0 |
| Investments | 3.89 | 0.31 | 0.31 | 0.81 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 31.19 | 37.85 | 40.6 | 43.5 | 54.71 | 58.64 | 43.75 | 11.03 | 10.88 |
| Total Assets | 58.43 | 66.56 | 69.1 | 75.45 | 77.73 | 73.92 | 57.2 | 22.92 | 22.07 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 12.76 | 7.28 | 3.24 | 2.84 | -7.5 | -6.77 | -0.45 | -0.27 | 0.09 |
| Cash from Investing Activity | -4.82 | -2.58 | -1.55 | -5.98 | -14.89 | 1.08 | 0.94 | -0.38 | 0.05 |
| Cash from Financing Activity | -7.48 | 0.98 | -2.88 | 1.28 | 23.8 | 2.16 | -0.26 | -0.14 | 0.04 |
| Net Cash Flow | 0.46 | 5.68 | -1.19 | -1.86 | 1.41 | -3.53 | 0.22 | -0.79 | 0.18 |
| Free Cash Flow | 12.78 | 7.28 | 3.24 | 2.86 | -22.48 | -6.77 | -0.45 | -0.27 | 0.09 |
| CFO/OP | 361 | 204 | 81 | 34 | -99 | 66 | 3 | 1 | -4 |

### Ratios

| Item | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 151.89 | 138.36 | 152.19 | 127.11 | 214.18 | 393.03 | 1302.46 | 225.21 | 1251.43 |
| Inventory Days | 159.11 | 235.55 | 273.09 | 240.68 | 262.43 | 241.17 | 66.54 | 40.16 | 69.3 |
| Days Payable | 114.78 | 180.48 | 239.65 | 153.77 | 208.96 | 179.85 | 256.98 | 128.95 | 1686.39 |
| Cash Conversion Cycle | 196.22 | 193.42 | 185.64 | 214.03 | 267.65 | 454.35 | 1112.02 | 136.43 | -365.66 |
| Working Capital Days | 138.29 | 120.38 | 138.83 | 162.84 | 259.03 | 579.3 | 1132.44 | 319.27 | 1003.75 |
| ROCE % | — | 7 | 7.37 | 14.32 | 11.12 | -21.27 | -32.62 | -82.37 | -19.11 |

## Shareholding Pattern

### annual

| Category | Sep 2016 |
| --- | --- |
| Promoters | 49.64% |
| DIIs | 1.49% |
| Public | 48.87% |
| No. of Shareholders | 1217 |

### Quarterly

| Category | Jun 2016 | Sep 2016 |
| --- | --- | --- |
| Promoters | 49.64% | 49.64% |
| DIIs | 1.49% | 1.49% |
| Public | 48.87% | 48.87% |
| No. of Shareholders | 1217 | 1217 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 5 / 2 / 12

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 953.84 | Sell |
| EMA (10) | 946.45 | Sell |
| SMA (20) | 1020.04 | Sell |
| EMA (20) | 984.35 | Sell |
| SMA (50) | 1028.89 | Sell |
| EMA (50) | 1028.56 | Sell |
| SMA (100) | 1091.35 | Sell |
| EMA (100) | 1078.86 | Sell |
| SMA (200) | 1198.89 | Sell |
| EMA (200) | 1141.52 | Sell |

### Oscillators — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 29.22 | Buy |
| MACD (12,26,9) | -39.54 | Sell |
| Stochastic (14,3,3) | 11.89 | Buy |
| ADX (14) | 28.31 | Buy |
| Williams %R (14) | -80.4 | Buy |
| ATR (14) | 35.45 | High Volatility |
| ROC (12) | -15.47 | Sell |
| Stoch RSI (14) | 10.64 | Buy |
| UO (7,14,28) | 41.44 | Neutral |

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 2026-03-09 | [Results - Revised Audited Financial Results For March 2025](https://www.bseindia.com/xml-data/corpfiling/AttachLive/156fdb54-4777-4ba6-85bf-24ff7e238844.pdf) |
| 2026-02-25 | [Results - Revised Audited Financial Results For The Year Ended March 31, 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7093ab23-3b06-41d5-8d88-de98fc1c1fd2.pdf) |
| 2026-02-20 | [Results - Unaudited Financial Results For Half Year Ended Sept 30, 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b2d4ec8f-401d-430a-8c19-79b7b86cbff6.pdf) |
| 2026-02-17 | [Board Meeting Intimation for Approval Of Unaudited Financial Results For HYE Sept 30, 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d305c994-4e7b-4806-8084-7fdd344d4141.pdf) |
| 2026-01-27 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/971eef58-f6b2-4d00-a63c-6b2525e2f278.pdf) |
| 2026-01-12 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/5ec7d76d-6567-4d09-886a-9e8cc5a99897.pdf) |
| 2026-01-12 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/59df1bf9-8a67-4429-b39c-8c912705ffea.pdf) |
| 2026-01-05 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018](https://www.bseindia.com/xml-data/corpfiling/AttachHis/19aeba66-33d7-4beb-a7e6-fd575d99ac25.pdf) |
| 2017-03-31 | [Outcome of AGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e4f3de39-5423-414f-a996-68a45df3a929.pdf) |
| 2017-03-31 | [Outcome of AGM](https://www.bseindia.com/xml-data/corpfiling/CorpAttachment/2017/3/e4f3de39-5423-414f-a996-68a45df3a929.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| 2025 | [Financial Year 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=971eef58-f6b2-4d00-a63c-6b2525e2f278.pdf) |
| 2023 | [Financial Year 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/5c505bd6-13e1-426f-8f65-86e80f9b7a68.pdf) |
| 2022 | [Financial Year 2022](https://www.bseindia.com/bseplus/AnnualReport/541178/76749541178.pdf) |
| 2021 | [Financial Year 2021](https://www.bseindia.com/bseplus/AnnualReport/541178/71721541178.pdf) |
| 2020 | [Financial Year 2020](https://www.bseindia.com/bseplus/AnnualReport/541178/68167541178.pdf) |
| Mar 2019 | [Financial Year 2019](https://www.bseindia.com/bseplus/AnnualReport/541178/5411780319.pdf) |
| Mar 2018 | [Financial Year 2018](https://www.bseindia.com/bseplus/AnnualReport/541178/5411780318.pdf) |
| Mar 2016 | [Annual Report 2016](https://www.bseindia.com/bseplus/AnnualReport/501209/5012090316.pdf) |
| Mar 2015 | [Annual Report 2015](https://www.bseindia.com/bseplus/AnnualReport/501209/5012090315.pdf) |
| Mar 2014 | [Annual Report 2014](https://www.bseindia.com/bseplus/AnnualReport/501209/5012090314.pdf) |

### Credit Rating Reports

| Date | Document |
| --- | --- |
| 2025-05-29 | Credit rating update — CARE Ratings |
| 2024-05-06 | Credit rating update — CARE Ratings |
| 2023-02-13 | Credit rating update — CARE Ratings |
| 2021-04-26 | Credit rating update — CARE Ratings |
| 2021-04-26 | Credit rating update — CARE Ratings |
| 2020-03-25 | Credit rating update — CARE Ratings |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-10-13T10:59:14.891Z.